Patents by Inventor Dilip B. Wadgaonkar

Dilip B. Wadgaonkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210077484
    Abstract: This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Applicant: Acura Pharmaceuticals, Inc.
    Inventors: Vijai KUMAR, David DIXON, Divya TEWARI, Dilip B. WADGAONKAR
  • Publication number: 20180028527
    Abstract: This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 1, 2018
    Applicant: Acura Pharmaceuticals, Inc.
    Inventors: Vijai KUMAR, David DIXON, Divya TEWARI, Dilip B. WADGAONKAR
  • Publication number: 20170049769
    Abstract: This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
    Type: Application
    Filed: November 7, 2016
    Publication date: February 23, 2017
    Applicant: Acura Pharmaceuticals, Inc.
    Inventors: Vijai KUMAR, David DIXON, Divya TEWARI, Dilip B. WADGAONKAR
  • Patent number: 9492443
    Abstract: This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: November 15, 2016
    Assignee: ACURA PHARMACEUTICALS, INC.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Publication number: 20140336213
    Abstract: This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
    Type: Application
    Filed: July 23, 2014
    Publication date: November 13, 2014
    Applicant: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 8822489
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: September 2, 2014
    Assignee: Acura Pharmaceuticals
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 8637540
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: January 28, 2014
    Assignee: Acura Pharmaceuticals
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Publication number: 20130289062
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Application
    Filed: June 25, 2013
    Publication date: October 31, 2013
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 8409616
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: April 2, 2013
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Publication number: 20120087982
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 12, 2012
    Applicant: ACURA PHARMACEUTICALS, INC.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 8101630
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: January 24, 2012
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 7981439
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: July 19, 2011
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Publication number: 20090253730
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Application
    Filed: March 30, 2009
    Publication date: October 8, 2009
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 7510726
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: March 31, 2009
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 7476402
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: January 13, 2009
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Publication number: 20090004292
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Application
    Filed: August 28, 2008
    Publication date: January 1, 2009
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar
  • Patent number: 7201920
    Abstract: This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: April 10, 2007
    Assignee: Acura Pharmaceuticals, Inc.
    Inventors: Vijai Kumar, David Dixon, Divya Tewari, Dilip B. Wadgaonkar